Prolonged xenograft survival induced by inducible costimulator-Ig Is associated with increased Forkhead Box P3+ Cells

Transplantation

Volumn 91, Issue 10, 2011, Pages 1090-1097

  Hodgson, Russell ^a   Christiansen, Dale ^a   Ziolkowski, Andrew ^b   Mouhtouris, Effie ^a   Simeonovic, Charmaine J ^b   Ierino, Francesco L ^a,c   Sandrin, Mauro S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Australian National University   (Australia)

^c AUSTIN HEALTH   (Australia)

Author keywords

Foxp3; ICOS Ig; Treg; Xenotransplantation

Indexed keywords

CD28 ANTIGEN; COMPLEMENTARY DNA; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN; IMMUNOGLOBULIN FC FRAGMENT; INDUCIBLE COSTIMULATOR; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; GRAFT SURVIVAL; ILIAC ARTERY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE; XENOTRANSPLANTATION;

ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELLS, CULTURED; CYTOKINES; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 79955591494     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31821774e0     Document Type: Article

References (50)

1. Lenschow D, Zeng Y, Thistlethwaite R, et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 1992; 257: 789.
2. Greenwald R, Freeman G, Sharpe A. The B7 family revisited. Annu Rev Immunol 2005; 23: 515.
3. Salomon B, Bluestone J. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001; 19: 225.
4. Bluestone JA, St. Clair EW, Turka LA. CTLA4Ig: Bridging the basic immunology with clinical application. Immunity 2006; 24: 233.
5. Epstein FH, Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998; 338: 1813.
6. Mulley W, Wee J, Christiansen D, et al. Lentiviral expression of CTLA4Ig inhibits primed xenogeneic lymphocyte proliferation and cytokine responses. Xenotransplantation 2006; 13: 248.
7. Gainer A, Korbutt G, Rajotte R, et al. Expression of CTLA4-Ig by biolistically transfected mouse islets promotes islet allograft survival. Transplantation 1997; 63: 1017.
8. Feng S, Quickel R, Hollister-Lock J, et al. Prolonged xenograft survival of islets infected with small doses of adenovirus expressing CTLA4Ig. Transplantation 1999; 67: 1607.
9. Olthoff K, Judge T, Gelman A, et al. Adenovirus-mediated gene transfer into cold-transduction with CTLA4Ig. Nat Med 1998; 4: 194.
10. Steurer W, Nickerson PW, Steele AW, et al. Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance. J Immunol 1995; 155: 1165.
11. Hutloff A, Dittrich A, Beier K, et al. ICOS is an inducible T-cell costimulator structurally and functionally related to CD28. Nature 1999; 397: 263.
12. Yoshinaga S, Whoriskey J, Khare S, et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature 1999; 402: 827.
13. Guo L, Li X-K, Funeshima N, et al. Prolonged survival in rat liver transplantation with mouse monoclonal antibody against an inducible costimulator (ICOS)1. Transplantation 2002; 73: 1027.
14. Chen Y, Liu H, Liu Z, et al. Blockade of inducible costimulator pathway to prevent acute rejection in rat liver transplantation. Am J Surg 2009; 198: 244.
15. Nakamura Y, Yasunami Y, Satoh M, et al. Acceptance of islet allografts in the liver of mice by blockade of an inducible costimulator. Transplantation 2003; 75: 1115.
16. Nabeyama K, Yasunami Y, Toyofuku A, et al. Beneficial effects of costimulatory blockade with anti-inducible costimulator antibody in conjunction with CTLA4Ig on prevention of islet xenograft rejection from rat to mouse. Transplantation 2004; 78: 1590.
17. Ö zkaynak E, Gao W, Shemmeri N, et al. Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat Immunol 2001; 2: 591.
18. Kosuge H, Suzuki J-I, Gotoh R, et al. Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway. Transplantation 2003; 75: 1374.
19. + T cells. Eur J Immunol 2006; 36: 2601.
20. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22: 531.
21. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006; 212: 8.
22. Joffre O, Santolaria T, Calise D, et al. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat Med 2008; 14: 88.
23. Kawai T, Cosimi A, Spitzer T, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358: 353.
24. Koshiba T, Li Y, Takemura M, et al. Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transpl Immunol 2007; 17: 94.
25. Porter C, Bloom E. Human CD4+CD25+ regulatory T cells suppress anti-porcine xenogeneic responses. Am J Transplant 2005; 5: 2052.
26. Lin Y-J, Hara H, Tai H-C, et al. Suppressive efficacy and proliferative capacity of human regulatory T cells in allogeneic and xenogeneic responses. Transplantation 2008; 86: 1452.
27. Chen D, Bromberg J. T regulatory cells and migration. Am J Transplant 2006; 6: 1518.
28. + T helper cells. Eur J Immunol 2004; 34: 1303.
29. Clarkson M, Sayegh MH. T-cell costimulatory pathways in allograft rejection and tolerance. Transplantation 2005; 80: 555.
30. Mulley WR, Li YQ, Wee JL, et al. Local expression of IDO, either alone or in combination with CD40Ig, IL10 or CTLA4Ig, inhibits indirect xenorejection responses. Xenotransplantation 2008; 15: 174.
31. Sandrin MS, McKenzie IFC. Transgenic animals and xenotransplantation. Curr Opin Organ Transplant 1997; 2: 116.
32. Sandrin MS, McKenzie IFC. Current status of genetic modification and cloning for xenografting. Curr Opin Organ Transplant 2001; 6: 26.
33. Wang G, Zhu L, Hu P, et al. The inhibitory effects of mouse ICOS-Ig gene-modified mouse dendritic cells on T cells. Cell Mol Immunol 2004; 1: 153.
34. Aicher A, Hayden-Ledbetter M, Brady W, et al. Characterization of human inducible costimulator ligand expression and function. J Immunol 2000; 164: 4689.
35. + T Cells. J Immunol 2000; 165: 5035.
36. Salama AD, Yuan X, Nayer A, et al. Interaction between ICOS-B7RP1 and B7-CD28 costimulatory pathways in alloimmune responses in vivo. Am J Transplant 2003; 3: 390.
37. Lutz J, Lu R, Strobl M, et al. ICOS/B7RP-1 interference in mouse kidney transplantation. Transplantation 2007; 84: 223.
38. Fabian D, Gong N, Vogt K, et al. The influence of inducible costimulator fusion protein (ICOSIg) gene transfer on corneal allograft survival. Graefe's Arch Clin Exp Ophthalmol 2007; 245: 1515.
39. Watson M, George A, Larkin D. Differential effects of costimulatory pathway modulation on corneal allograft survival. Invest Ophthalmol Vis Sci 2006; 47: 3417.
40. + regulatory T cells in solid organ transplantation. Curr Opin Organ Transplant 2010; 15: 757.
41. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199.
42. Muller YD, Golshayan D, Ehirchiou D, et al. T regulatory cells in xenotransplantation. Xenotransplantation 2009; 16: 121.
43. O'Connell PJ, Yi S, Carrington EM, et al. Role of regulatory T cells in xenotransplantation. Curr Opin Organ Transplant 2010; 15: 224.
44. Wu J, Yi S, Ouyang L, et al. In vitro expanded human CD4+CD25+ regulatory T cells are potent suppressors of T-cell-mediated xenogeneic responses. Transplantation 2008; 85: 1841.
45. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151.
46. Thornton AM, Shevach EM. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 2000; 164: 183.
47. Sun L, Yi S, O'Connell PJ. IL-10 is required for human CD4+CD25+ regulatory T cell-mediated suppression of xenogeneic proliferation. Immunol Cell Biol 2010; 88: 477.
48. Heffernan M, Dennis JW. Polyoma and hamster papovavirus large T antigen-mediated replication of expression shuttle vectors in Chinese hamster ovary cells. Nucleic Acids Res 1991; 19: 85.
49. Ierino FL, Mulley W, Dodge N, et al. Dendritic cells expressing soluble CTLA4Ig prolong antigen-specific skin graft survival. Immunol Cell Biol 2010; 88: 846.
50. McKenzie IF, Koulmanda M, Mandel TE, et al. Pig islet xenografts are susceptible to "anti-pig" but not Gal alpha(1,3)Gal antibody plus complement in Gal o/o mice. J Immunol 1998; 161: 5116.